Karpus Investment Management’s NRX Pharmaceuticals NRXP Stock Holding History

Karpus Investment Management’s Portfolio NRXP Stock Details NRXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-20,879	Closed	-$2.16M	–	201
2019 Q1	$2.16M	Sell	20,879 -33	-0.2%	-$3.39K	0.08%	133
2018 Q4	$2.13M	Sell	20,912 -4,190	-17%	-$423K	0.09%	128
2018 Q3	$2.51M	Sell	25,102 -190	-0.8%	-$18.9K	0.1%	105
2018 Q2	$2.51M	Buy	25,292 +143	+0.6%	+$14.1K	0.11%	90
2018 Q1	$2.47M	Buy	25,149 +16,039	+176%	+$1.56M	0.11%	95
2017 Q4	$884K	Buy	+9,110	New	+$881K	0.04%	110

Other funds holding NRXP

MSU

Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.71% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.36B AUM 25.57% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $351M AUM 21.8% 1-Year Est. Return

Karpus Investment Management's NRXP Position: Q2 2019 in Review

Karpus Investment Management sold out of NRX Pharmaceuticals (NRXP) in Q2 2019, closing a stake of 20,879 shares — an estimated $2.16M sold.

Karpus Investment Management first reported a position in NRXP in Q4 2017 and held it in 6 quarters. The position peaked at $2.51M in Q3 2018. 17 funds tracked by Wall St. Rank hold NRXP as of Q2 2019.

Karpus Investment Management reported no remaining NRX Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
Karpus Investment Management sold 20,879 NRX Pharmaceuticals shares in Q2 2019, an estimated $2.16M.
Karpus Investment Management first reported a position in NRX Pharmaceuticals in Q4 2017 and held it in 6 quarters.
Karpus Investment Management's NRX Pharmaceuticals position peaked at $2.51M in Q3 2018.
17 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q2 2019.

Based on Karpus Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.